Member News
-
Hemostemix Announces Phase II Results Plus New Heart Study Demonstrating Statistically Significant Improvement in Ejection Fraction at 4 and 12 Months after ACP-01 Heart Injections
August 30, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to…
-
Power Nickel Files the NI 43-101 Technical Report for the Mineral Resource Estimate of the Nisk Project
August 30, 2022 (Source) – Power Nickel Inc. (the “Company” or “Power Nickel”) (TSX-V:PNPN)(OTCBB:CMETF)(Frankfurt IVVI) has filed on SEDAR the…
-
Valeo Pharma Adds Pharmaceutical Industry Veteran Kyle Steiger to Leadership Team
Kyle Steiger appointed Senior Vice-President and Chief Commercial Officer Jean-François Fournier appointed new Business Unit Head – Ophthalmology August 30, 2022…
-
Imperial Mining Announces its Intent to Extend the Expiry Date of Warrants
August 29, 2022 (Source) – Imperial Mining Group Ltd. (“Imperialˮ or the “Corporation”) (TSX VENTURE: IPG; OTCQB: IMPNF) announces its…
-
Neo Performance Materials Announces $67.5 Million Bought Deal Treasury Offering of Common Shares
August 26, 2022 (Source) – Neo Performance Materials Inc. (TSX: NEO) (“Neo” or the “Company”) announces that it has entered into an…
-
Agreement to acquire strategic shareholding in Neo Performance Materials and cornerstone investment in Hastings by Wyloo Metals
August 26, 2022 (Source) – Highlights Hastings to acquire a 22.1% strategic shareholding in Neo Performance Materials Inc., a…
-
Awakn Life Sciences Signs Agreement with a Leading Drug Development Company to Deepen IP Moat for Its Lead Program
Agreement Provides 12-Month Exclusive Period to Agree in-Licensing Deal for Proprietary Formulation of Ketamine August 25, 2022 (Source)…
-
dynaCERT Advances its Verified Carbon Standard Application with Verra
August 25, 2022 (Source) – dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (“dynaCERT” or the “Company”) is…
